ClinicalTrials.Veeva

Menu
D

DermResearch, Inc. | Austin, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Adapalene
PEP005
Tazarotene
Glycopyrronium
Ingenol Mebutate
Bimatoprost
MT10109L
imiquimod
122-0551
RPT193

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 137 total trials
Locations recently updated

A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants

The masseter muscle is one of the muscles in the lower face used for chewing. The prominence of the masseter muscle can appear as a widened lower fac...

Enrolling
Masseter Muscle Prominence
Drug: Placebo
Drug: BOTOX

The purpose of the study is to see if Clascoterone can help people with male pattern hair loss to recovery and see if the treatment is effective and...

Enrolling
Alopecia, Androgenetic
Drug: Clascoterone 5% solution
Drug: Vehicle solution
Locations recently updated

The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).

Enrolling
Prurigo Nodularis
Drug: Ruxolitinib Cream
Drug: Vehicle Cream
Locations recently updated

This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Pr...

Enrolling
Prurigo Nodularis
Drug: Ruxolitinib Cream 1.5%

This is a Phase 3 multicenter, double-blind study to evaluate the safety and efficacy of vehicle-controlled topical MOB015B in the treatment of Dista...

Active, not recruiting
Onychomycosis
Drug: MOB015B
Drug: Vehicle (Placebo Comparator)

The goal of this clinical trial is to compare outcome in healthy subjects 12 years of age and older with at least 3, but no more than 20, common wart...

Enrolling
Common Warts (Verruca Vulgaris)
Drug: Candin, Intradermal Solution
Drug: Placebo

The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with mode...

Enrolling
Acne Vulgaris
Drug: DMT310
Drug: Placebo

Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar...

Enrolling
Wound Healing
Scar
Drug: SLI-F06

This is a Pre-IDE, prospective, multicenter, randomized, parallel-group, double-blind, vehicle- controlled study to evaluate safety and effectiveness...

Enrolling
Distal Lateral Subungual Onychomycosis
Onychomycosis
Device: Nail Genesis DLSO Product
Device: Nail Genesis DLSO Product (vehicle only)

The study is designed to validate safety results from the Phase 1 PP405-001 trial while also characterizing longer term safety and PK following 28 da...

Active, not recruiting
Androgenetic Alopecia
Drug: PP405 Topical Vehicle Gel
Drug: PP405 0.05% Topical Gel

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of one or two intramuscular injections of the Acne mRNA vaccine candi...

Enrolling
Acne
Biological: Acne mRNA vaccine
Other: Placebo

Trial sponsors

Galderma logo
Allergan logo
D
D
P
Pfizer logo
S
T
D
J

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems